MedTrace Logo

Superficial Cervical Nerve Block vs NSAIDs for the Relief of Shoulder Pain After Laparoscopic Surgeries

NCT02793323 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-11-06

No results posted yet for this study

Summary

Shoulder pain is frequently mentioned in recent literature following laparoscopic operations. Several pain relief strategies have been proposed to decrease shoulder tip pain post laparoscopic surgeries. This study will be conducted to compare the Superficial cervical nerve block vs. NSAIDs in terms of shoulder tip pain relief after laparoscopic surgeries.

Conditions

  • Relieve Shoulder Pain After Laparoscopic Surgeries

Interventions

OTHER

Superficial cervical nerve block

A nerve stimulator is used to guide superficial cervical blockade to relieve shoulder pain.

OTHER

NSAID

100 mg (100 ml) intravenous NSAIDs (Profenid)

OTHER

General anesthesia

General anesthesia is induced with 1 μg/kg fentanyl, 1.5-2 mg/kg propofol and 1-2 mg midazolam. Then, endotracheal intubation is facilitated by 0.15 mg/kg nimbex. Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 μg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen

OTHER

IV placebo

100 ml IV saline

OTHER

Placebo superficial cervical nerve block

Superficial cervical nerve block containing 5 ml saline

Sponsors & Collaborators

  • Makassed General Hospital

    lead OTHER

Principal Investigators

  • Zoher Naja, MD · Makassed General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2017-08-31
Completion
2017-09-30

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793323 on ClinicalTrials.gov